Beilloso Balanitis Relief Cream
Product Images NDC 85248-138

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Beilloso Balanitis Relief (NDC 85248-138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jiangxi Yudexi Pharmaceutical Co., Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

2 (0a1ebbf225405dc405b04d1de2b5f73d)

2 (0a1ebbf225405dc405b04d1de2b5f73d)
This is a description of Beilloso™ Men's Private Balanitis Relief Cream. It contains 2% Miconazole Nitrate to reduce inflammation and soothe irritated skin. The cream helps relieve redness, itching, and irritation from balanitis, as well as discomfort from fungal skin conditions in sensitive areas. It is for external use only and should not be used on children under 2 years old without doctor's direction. If eye contact occurs, rinse thoroughly with water. If irritation persists or worsens, consult a doctor. It is essential to keep the cream out of reach of children and seek medical help if ingested. The directions suggest applying 2 pumps of cream to affected areas 1-2 times daily on clean, dry skin. Before full use, a small patch test is recommended for first-time users. Inactive ingredients include water, allantoin, beeswax, cedarwood oil, cottonseed oil, jojoba oil, lavender oil, magnesium oxide, MCT oil, silver stearate, and zinc oxide. The cream should be stored between 59-86°F (15-30°C).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.